Hookipa Pharma Inc. Insider Trading

HOOK

⊜ Compare

Last 12 months

No open-market buying or selling by insiders.

The last open-market buy by an executive or director was in Aug 2023.

Net open-market

0 buys · 0 sales

Under a 10b5-1 plan

—

no sales

Insiders who bought / sold

0 / 0

executives and directors

Last open-market buy

Aug 2023

Aug 21, 2023

Get an email when HOOK's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Aug 19, 2025	Malte Peters Chief Executive Officer	SoldNo plan	25,172	$0.82	21K	32%	Form 4
Jul 22, 2025	Malte Peters Chief Executive Officer	SoldNo plan	29,176	$0.92	27K	27%	Form 4
Jul 22, 2025	Mary Theresa Coelho EVP and CFO	SoldNo plan	13,609	$0.92	13K	19%	Form 4

Aug 19, 2025No plan
Malte Peters
Chief Executive Officer · sold 25,172 at $0.82
21K
32% of stake
Jul 22, 2025No plan
Malte Peters
Chief Executive Officer · sold 29,176 at $0.92
27K
27% of stake
Jul 22, 2025No plan
Mary Theresa Coelho
EVP and CFO · sold 13,609 at $0.92
13K
19% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch HOOK, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with HOOK

CompareIntrinsic value

ISCOInternational Stem Cell Corporation

$0.14+0.00%29

PGENPrecigen Inc.

$5.06-3.71%0

ZBIOZenas BioPharma, Inc.

$28.46+0.28%10

EVMNEvommune, Inc.

$6.04+1.68%35

BIOABioAge Labs, Inc.

$5.95-0.17%10

ACRSAclaris Therapeutics, Inc.

$3.68-1.60%10

COYACoya Therapeutics Inc.

$3.08-0.96%10

CBIOCrescent Biopharma, Inc.

$13.42+2.76%50

Spot a number that looks wrong? Check it in HOOK's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing HOOK

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.